Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia

Blood

Volumn 100, Issue 5, 2002, Pages 1810-1816

  Bellosillo, Beatriz ^a,b,c   Villamor, Neus ^a,b,c   López Guillermo, Armando ^a,b,c   Marcé, Silvia ^a,b,c   Bosch, Francesc ^a,b,c   Campo, Elias ^a,b,c   Montserrat, Emili ^a,b,c,d   Colomer, Dolors ^a,b,c  

^a Institute of Hematology and Oncology from Hospital Clínic   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE INHIBITOR; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUDARABINE; MAFOSFAMIDE; MITOXANTRONE; PHOSPHATIDYLSERINE; PROTEIN BAK; PROTEIN BAX; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONFORMATIONAL TRANSITION; CORRELATION ANALYSIS; ENZYME INHIBITION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION;

EID: 0036721455     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2001-12-0327     Document Type: Article

References (46)

1. Chronic lymphocytic leukemia
2. Molecular biology of chronic lymphocytic leukemia
3. Novel therapies for chronic lymphocytic leukemia in the 21st century
4. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine
5. Chlorambucil induced apoptosis in chronic lymphocytic leukemia (CLL) and its relationship to clinical efficacy
6. Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells
7. In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia
8. Cellular stress response and apoptosis in cancer therapy
9. Life-or-death decisions by the Bcl-2 protein family
10. BCL-2 family members and the mitochondria in apoptosis
11. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis
12. Conformation of the Bax C-terminus regulates subcellular location and cell death
13. Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis
14. Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia
15. Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome
16. Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukaemia
17. Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance
18. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: Correlations with in vitro and in vivo chemoresponses
19. Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia
20. Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species
21. A role for mitochondrial Bak in apoptotic response to anticancer drugs
22. Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells
23. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations
24. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis
25. Up-regulation of the proapoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung cancer cells
26. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
27. Bcl-2 and Bax function independently to regulate cell death
28. p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release
29. Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak
30. Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization
31. Recent progress on regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive pore in the inner mitochondrial membrane
32. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis
33. Structure of Bax: Coregulation of dimer formation and intracellular localization
34. Regulated targeting of BAX to mitochondria
35. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death
36. Cisplatin induces the proapoptotic conformation of Bak in a deltaMEKK1-dependent manner
37. Resistance to granzyme B-mediated cytochrome c release in Bak-deficient cells
38. Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis
39. Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH
40. Na+/H+ antiporter has different properties in human B lymphocytes according to CD5 expression and malignant phenotype
41. Na+/H+ exchange activation mediates the lipopolysaccharide-induced proliferation of human B lymphocytes and is impaired in malignant B-chronic lymphocytic leukemia lymphocytes
42. Bax is a transcriptional target and mediator of c-myc-induced apoptosis
43. DNA microarrays identification of primary and secondary target genes regulated by p53
44. Death signal-induced localization of p53 protein to mitochondria: A potential role in apoptotic signaling
45. Bcl-B, a novel Bcl-2 family member that differentially binds and regulates Bax and Bak